Today’s lineup in the Blood Journals Studio! #bloodjournals #ASH24
December 8, 2024 at 4:34 PM
Today’s lineup in the Blood Journals Studio! #bloodjournals #ASH24
Send your malignant hematology work presented at #ASH24 to @bloodneoplaisa.bsky.social, Editor-in-chief Jonathan Licht @jdlicht.bsky.social and I look forward to helping you publish your work #bloodjournals
December 7, 2024 at 5:45 AM
Send your malignant hematology work presented at #ASH24 to @bloodneoplaisa.bsky.social, Editor-in-chief Jonathan Licht @jdlicht.bsky.social and I look forward to helping you publish your work #bloodjournals
Explore the latest issue of Blood Neoplasia: ashpublications.org/bloodneoplas... #BloodJournals #BloodNeoplasia #Hemesky
November 25, 2025 at 6:06 PM
Explore the latest issue of Blood Neoplasia: ashpublications.org/bloodneoplas... #BloodJournals #BloodNeoplasia #Hemesky
This press release highlights how patients with sickle cell disease in vaso-occlusive crisis are often under-triaged resulting in poor adherence to pain management guidelines. Read the study in Blood Advances here: ashpublications.org/bloodadvance... #SickleCellDisease #BloodJournals #Hematology
Patients with sickle cell disease often wait hours for pain relief in the ER when triage doesn’t follow guidelines. Proper Emergency Severity Index (ESI) scoring can dramatically speed access to medication. https://ow.ly/s3aQ50X8xKM
#ConquerSCD #SickleCell #HemeSky
#ConquerSCD #SickleCell #HemeSky
October 8, 2025 at 3:39 PM
This press release highlights how patients with sickle cell disease in vaso-occlusive crisis are often under-triaged resulting in poor adherence to pain management guidelines. Read the study in Blood Advances here: ashpublications.org/bloodadvance... #SickleCellDisease #BloodJournals #Hematology
ICYMI: Blood Neoplasia and Blood VTH are now indexed in PubMed! Your research in hematologic malignancies or vascular biology, thrombosis, and hemostasis will now be more discoverable than ever. Submit today: buff.ly/OcEH3eB #PubMed #BloodJournals #Hematology
September 29, 2025 at 5:35 PM
ICYMI: Blood Neoplasia and Blood VTH are now indexed in PubMed! Your research in hematologic malignancies or vascular biology, thrombosis, and hemostasis will now be more discoverable than ever. Submit today: buff.ly/OcEH3eB #PubMed #BloodJournals #Hematology
🔊Mutations in AMBRA1 aggravate β-thalassemia; targeting MYD88 mutations in lymphomas; air pollution and incident VTE risk
🎧https://buff.ly/ERwOymO #bloodjournals
🎧https://buff.ly/ERwOymO #bloodjournals
March 6, 2025 at 9:00 PM
🔊Mutations in AMBRA1 aggravate β-thalassemia; targeting MYD88 mutations in lymphomas; air pollution and incident VTE risk
🎧https://buff.ly/ERwOymO #bloodjournals
🎧https://buff.ly/ERwOymO #bloodjournals
🚨Latest Blood issue out now featuring:
Spotlight: variant BTK resistance mutations in CLL
Review: myeloid contributions to immunotherapy outcomes
buff.ly/TQNxDCx #bloodjournals
Spotlight: variant BTK resistance mutations in CLL
Review: myeloid contributions to immunotherapy outcomes
buff.ly/TQNxDCx #bloodjournals
March 6, 2025 at 7:00 PM
🚨Latest Blood issue out now featuring:
Spotlight: variant BTK resistance mutations in CLL
Review: myeloid contributions to immunotherapy outcomes
buff.ly/TQNxDCx #bloodjournals
Spotlight: variant BTK resistance mutations in CLL
Review: myeloid contributions to immunotherapy outcomes
buff.ly/TQNxDCx #bloodjournals
📣Congratulations to Blood Red Cell Iron's first published paper!
Itaconate promotes the differentiation of murine stress erythroid progenitors by increasing Nrf2 activity buff.ly/4bkzcUi <a href="/hashtag/bloodjournals" class="hover:underline text-blue-600 dark:text-sky-400 no-card-link">#bloodjournals
Itaconate promotes the differentiation of murine stress erythroid progenitors by increasing Nrf2 activity buff.ly/4bkzcUi <a href="/hashtag/bloodjournals" class="hover:underline text-blue-600 dark:text-sky-400 no-card-link">#bloodjournals
February 28, 2025 at 7:01 PM
📣Congratulations to Blood Red Cell Iron's first published paper!
Itaconate promotes the differentiation of murine stress erythroid progenitors by increasing Nrf2 activity buff.ly/4bkzcUi <a href="/hashtag/bloodjournals" class="hover:underline text-blue-600 dark:text-sky-400 no-card-link">#bloodjournals
Itaconate promotes the differentiation of murine stress erythroid progenitors by increasing Nrf2 activity buff.ly/4bkzcUi <a href="/hashtag/bloodjournals" class="hover:underline text-blue-600 dark:text-sky-400 no-card-link">#bloodjournals
🚨New issue of Blood out now featuring:
Review Series: 25 years of TKIs in CML
buff.ly/4khznE8 <a href="/hashtag/bloodjournals" class="hover:underline text-blue-600 dark:text-sky-400 no-card-link">#bloodjournals
Review Series: 25 years of TKIs in CML
buff.ly/4khznE8 <a href="/hashtag/bloodjournals" class="hover:underline text-blue-600 dark:text-sky-400 no-card-link">#bloodjournals
February 27, 2025 at 7:01 PM
🚨New issue of Blood out now featuring:
Review Series: 25 years of TKIs in CML
buff.ly/4khznE8 <a href="/hashtag/bloodjournals" class="hover:underline text-blue-600 dark:text-sky-400 no-card-link">#bloodjournals
Review Series: 25 years of TKIs in CML
buff.ly/4khznE8 <a href="/hashtag/bloodjournals" class="hover:underline text-blue-600 dark:text-sky-400 no-card-link">#bloodjournals
📣New Blood VTH issue out now featuring:
Disorders of platelet number and function: basic and translational
https://buff.ly/41aW980 #bloodjournals
Disorders of platelet number and function: basic and translational
https://buff.ly/41aW980 #bloodjournals
February 26, 2025 at 7:01 PM
📣New Blood VTH issue out now featuring:
Disorders of platelet number and function: basic and translational
https://buff.ly/41aW980 #bloodjournals
Disorders of platelet number and function: basic and translational
https://buff.ly/41aW980 #bloodjournals
🚨New issue of Blood Neoplasia out now featuring:
Enitociclib, a selective CDK9 inhibitor: in vitro and in vivo preclinical studies in multiple myeloma https://buff.ly/3XiCcuL #bloodjournals
Enitociclib, a selective CDK9 inhibitor: in vitro and in vivo preclinical studies in multiple myeloma https://buff.ly/3XiCcuL #bloodjournals
February 26, 2025 at 7:00 PM
🚨New issue of Blood Neoplasia out now featuring:
Enitociclib, a selective CDK9 inhibitor: in vitro and in vivo preclinical studies in multiple myeloma https://buff.ly/3XiCcuL #bloodjournals
Enitociclib, a selective CDK9 inhibitor: in vitro and in vivo preclinical studies in multiple myeloma https://buff.ly/3XiCcuL #bloodjournals
🚨New Blood Advances issue out now featuring Inside Blood Advances:
How donor age affects RBC deformability in storage
Testicular follicular lymphoma: let me count the ways
The transplant debate: defining innovation for sickle cell https://buff.ly/435x7JN #bloodjournals
How donor age affects RBC deformability in storage
Testicular follicular lymphoma: let me count the ways
The transplant debate: defining innovation for sickle cell https://buff.ly/435x7JN #bloodjournals
February 25, 2025 at 7:00 PM
🚨New Blood Advances issue out now featuring Inside Blood Advances:
How donor age affects RBC deformability in storage
Testicular follicular lymphoma: let me count the ways
The transplant debate: defining innovation for sickle cell https://buff.ly/435x7JN #bloodjournals
How donor age affects RBC deformability in storage
Testicular follicular lymphoma: let me count the ways
The transplant debate: defining innovation for sickle cell https://buff.ly/435x7JN #bloodjournals
Blood Global Hematology Editor-in-Chief, Dr. Jorge Cortes at the ASH booth at HOA Asia!
#bloodjournals
#bloodjournals
February 24, 2025 at 4:02 PM
Blood Global Hematology Editor-in-Chief, Dr. Jorge Cortes at the ASH booth at HOA Asia!
#bloodjournals
#bloodjournals
📣Blood Global Hematology is now open for submissions. Submit your research!
https://buff.ly/43pfZ2b #bloodjournals
https://buff.ly/43pfZ2b #bloodjournals
February 24, 2025 at 3:18 PM
📣Blood Global Hematology is now open for submissions. Submit your research!
https://buff.ly/43pfZ2b #bloodjournals
https://buff.ly/43pfZ2b #bloodjournals
📣Blood Global Hematology is now open for submissions. Submit your research!
https://buff.ly/43pfZ2b #bloodjournals
https://buff.ly/43pfZ2b #bloodjournals
February 21, 2025 at 1:00 PM
📣Blood Global Hematology is now open for submissions. Submit your research!
https://buff.ly/43pfZ2b #bloodjournals
https://buff.ly/43pfZ2b #bloodjournals
📣🚨 Blood Global Hematology has published their first article, Hydroxyurea to Decrease Stroke Risk in Children with Sickle Cell Anemia: A Systematic Review and Meta-analysis. https://buff.ly/3QwBUfO #bloodjournals
February 20, 2025 at 8:00 PM
📣🚨 Blood Global Hematology has published their first article, Hydroxyurea to Decrease Stroke Risk in Children with Sickle Cell Anemia: A Systematic Review and Meta-analysis. https://buff.ly/3QwBUfO #bloodjournals
🩸New Blood issue out now featuring:
How I Treat: quantitative fibrinogen disorders
https://buff.ly/41bjOFr #bloodjournals
How I Treat: quantitative fibrinogen disorders
https://buff.ly/41bjOFr #bloodjournals
February 20, 2025 at 7:01 PM
🩸New Blood issue out now featuring:
How I Treat: quantitative fibrinogen disorders
https://buff.ly/41bjOFr #bloodjournals
How I Treat: quantitative fibrinogen disorders
https://buff.ly/41bjOFr #bloodjournals
🚨 📣The Blood Art Contest winner has been selected! 🎉Congratulations to Alan G. Ramsay and co-authors! https://buff.ly/4b4PFfl #bloodjournals
February 14, 2025 at 2:00 PM
🚨 📣The Blood Art Contest winner has been selected! 🎉Congratulations to Alan G. Ramsay and co-authors! https://buff.ly/4b4PFfl #bloodjournals
🎉Congratulations to the Blood Cover Art Contest winner, Alan G. Ramsay and co-authors!
https://buff.ly/4b4PFfl #bloodjournals
https://buff.ly/4b4PFfl #bloodjournals
February 13, 2025 at 9:04 PM
🎉Congratulations to the Blood Cover Art Contest winner, Alan G. Ramsay and co-authors!
https://buff.ly/4b4PFfl #bloodjournals
https://buff.ly/4b4PFfl #bloodjournals
🩸New Blood issue out now featuring:
Review Series: mantle cell lymphoma
https://buff.ly/4ifo39V #bloodjournals
Review Series: mantle cell lymphoma
https://buff.ly/4ifo39V #bloodjournals
February 13, 2025 at 7:07 PM
🩸New Blood issue out now featuring:
Review Series: mantle cell lymphoma
https://buff.ly/4ifo39V #bloodjournals
Review Series: mantle cell lymphoma
https://buff.ly/4ifo39V #bloodjournals
🚨 📣The Blood Art Contest winner has been selected! 🎉Congratulations to Alan G. Ramsay and co-authors! https://buff.ly/4b4PFfl #bloodjournals
February 13, 2025 at 5:00 PM
🚨 📣The Blood Art Contest winner has been selected! 🎉Congratulations to Alan G. Ramsay and co-authors! https://buff.ly/4b4PFfl #bloodjournals
🚨 New Blood Advances issue out now featuring Inside Blood Advances:
IDCH: is it now determined?
PETAL: a global view or R/R T-/NK-lymphoma treatment reality
Caregiver signaling questions in sickle cell disease https://buff.ly/3WVVmq8 #bloodjournals
IDCH: is it now determined?
PETAL: a global view or R/R T-/NK-lymphoma treatment reality
Caregiver signaling questions in sickle cell disease https://buff.ly/3WVVmq8 #bloodjournals
February 11, 2025 at 8:05 PM
🚨 New Blood Advances issue out now featuring Inside Blood Advances:
IDCH: is it now determined?
PETAL: a global view or R/R T-/NK-lymphoma treatment reality
Caregiver signaling questions in sickle cell disease https://buff.ly/3WVVmq8 #bloodjournals
IDCH: is it now determined?
PETAL: a global view or R/R T-/NK-lymphoma treatment reality
Caregiver signaling questions in sickle cell disease https://buff.ly/3WVVmq8 #bloodjournals
🔊First-line zanubrutinib, obinutuzumab, and venetoclax in mantle cell lymphoma; hyperdiploidy in multiple myeloma; and pegcrisantaspase plus venetoclax in relapsed/refractory acute myeloid leukemia 🎧https://buff.ly/4jxtgLH #bloodjournals
buff.ly
February 5, 2025 at 4:00 PM
🔊First-line zanubrutinib, obinutuzumab, and venetoclax in mantle cell lymphoma; hyperdiploidy in multiple myeloma; and pegcrisantaspase plus venetoclax in relapsed/refractory acute myeloid leukemia 🎧https://buff.ly/4jxtgLH #bloodjournals
🔊First-line zanubrutinib, obinutuzumab, and venetoclax in mantle cell lymphoma; hyperdiploidy in multiple myeloma; and pegcrisantaspase plus venetoclax in relapsed/refractory acute myeloid leukemia 🎧https://buff.ly/4jxtgLH #bloodjournals
buff.ly
February 4, 2025 at 1:00 PM
🔊First-line zanubrutinib, obinutuzumab, and venetoclax in mantle cell lymphoma; hyperdiploidy in multiple myeloma; and pegcrisantaspase plus venetoclax in relapsed/refractory acute myeloid leukemia 🎧https://buff.ly/4jxtgLH #bloodjournals
